These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16963622)

  • 21. Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery.
    Moore MC; Burish MJ; Farmer B; Neal DW; Pan C; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E845-53. PubMed ID: 12773306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog.
    An Z; DiCostanzo CA; Moore MC; Edgerton DS; Dardevet DP; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E300-6. PubMed ID: 18029444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux.
    Yoshii H; Lam TK; Gupta N; Goh T; Haber CA; Uchino H; Kim TT; Chong VZ; Shah K; Fantus IG; Mari A; Kawamori R; Giacca A
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1089-97. PubMed ID: 16390863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human proinsulin: bioactivity and pharmaco-kinetics after intravenous and subcutaneous administration.
    Schatz H; Ammermann S
    Horm Metab Res Suppl; 1988; 18():1-5. PubMed ID: 3056805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AIR inhaled insulin in subjects with chronic obstructive pulmonary disease: pharmacokinetics, glucodynamics, safety, and tolerability.
    Rave K; de la Peña A; Tibaldi FS; Zhang L; Silverman B; Hausmann M; Heinemann L; Muchmore DB
    Diabetes Care; 2007 Jul; 30(7):1777-82. PubMed ID: 17456839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
    Bock G; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Chandramouli V; Landau BR; Rizza RA
    Diabetes; 2007 Jun; 56(6):1703-11. PubMed ID: 17384334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptation of feeding and counter-regulatory hormone responses to intermediate insulin-induced hypoglycaemia in the ovariectomised female rat: effects of oestradiol.
    Briski KP; Nedungadi TP
    J Neuroendocrinol; 2009 Jun; 21(6):578-85. PubMed ID: 19500228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose lowering effects of inhaled insulin in healthy cats.
    DeClue AE; Leverenz EF; Wiedmeyer CE; Bryan ME; Reinero CR
    J Feline Med Surg; 2008 Oct; 10(5):519-22. PubMed ID: 18602326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
    Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
    Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioactivity and pharmacokinetics of human proinsulin in comparison to human insulin after intravenous and subcutaneous injection.
    Schatz H; Ammermann S; Laube H; Federlin K
    Horm Metab Res; 1988 Jul; 20(7):445-9. PubMed ID: 3049293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin glargine has a long duration of effect following administration either once daily or twice daily in divided doses in healthy cats.
    Marshall RD; Rand JS; Morton JM
    J Feline Med Surg; 2008 Oct; 10(5):488-94. PubMed ID: 18703367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraindividual comparison of pharmacokinetics of insulin after intravenous, portal, subcutaneous and peritoneal administration.
    Fritze K; Fischer U; Freyse EJ; Besch W
    Exp Clin Endocrinol; 1988 Mar; 92(3):297-306. PubMed ID: 3075553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes.
    Skyler JS; Jovanovic L; Klioze S; Reis J; Duggan W;
    Diabetes Care; 2007 Mar; 30(3):579-85. PubMed ID: 17327324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simulated first-phase insulin release using Humulin or insulin analog HIM2 is associated with prolonged improvement in postprandial glycemia.
    DiCostanzo CA; Moore MC; Lautz M; Scott M; Farmer B; Everett CA; Still JG; Higgins A; Cherrington AD
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E46-52. PubMed ID: 15713685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
    Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
    Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes.
    Gredal C; Rosenfalck A; Dejgaard A; Hilsted J
    Diabetes Res Clin Pract; 2008 May; 80(2):293-8. PubMed ID: 18304675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of inhaled insulin (AERx iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trial.
    Moses RG; Bartley P; Lunt H; O'Brien RC; Donnelly T; Gall MA; Vesterager A; Wollmer P; Roberts A
    Diabet Med; 2009 Mar; 26(3):260-7. PubMed ID: 19317821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inclusion of low amounts of fructose with an intraportal glucose load increases net hepatic glucose uptake in the presence of relative insulin deficiency in dog.
    Shiota M; Galassetti P; Igawa K; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1160-7. PubMed ID: 15671083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines.
    Ansari G; Mojtahedzadeh M; Kajbaf F; Najafi A; Khajavi MR; Khalili H; Rouini MR; Ahmadi H; Abdollahi M
    Adv Ther; 2008 Jul; 25(7):681-702. PubMed ID: 18636232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.